ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VICTOR CORBETT MD

Endocrinology, Diabetes Metabolism

6,759

$645K

358
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 42%

$95
Average prescription price

Avg: $140

LAWRENCE MULMED MD FACE

Endocrinology, Diabetes Metabolism

6,612

$1.02M

471
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 42%

$154
Average prescription price

Avg: $140

MUNIR ABID MD

Endocrinology, Diabetes Metabolism

5,905

$719K

406
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 42%

$122
Average prescription price

Avg: $140

HAROLD KATZ MD

Endocrinology, Diabetes Metabolism

5,789

$757K

391
288 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 42%

$131
Average prescription price

Avg: $140

JOSEPH GONZALEZ-CAMPOY M.D., PH.D.

Endocrinology, Diabetes Metabolism

4,756

$438K

272
150 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 42%

$92
Average prescription price

Avg: $140

CRISPIN SEMAKULA MD

Endocrinology, Diabetes Metabolism

3,704

$368K

252
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 42%

$99
Average prescription price

Avg: $140

THOMAS SMITH MD

Endocrinology, Diabetes Metabolism

3,566

$385K

249
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 42%

$108
Average prescription price

Avg: $140

MARK STESIN M.D.

Endocrinology, Diabetes Metabolism

3,503

$511K

508
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 42%

$146
Average prescription price

Avg: $140

SIDNEY JONES MD

Endocrinology, Diabetes Metabolism

3,436

$485K

270
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 42%

$141
Average prescription price

Avg: $140

MARIA PATACSIL MD

Endocrinology, Diabetes Metabolism

3,297

$273K

277
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 42%

$83
Average prescription price

Avg: $140

JOHN BANTLE M.D.

Endocrinology, Diabetes Metabolism

3,232

$430K

217
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 42%

$133
Average prescription price

Avg: $140

DAVID STUART MD

Endocrinology, Diabetes Metabolism

3,201

$209K

110
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 42%

$65
Average prescription price

Avg: $140

JAMES WIBERG MD

Endocrinology, Diabetes Metabolism

3,084

$360K

173
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 42%

$117
Average prescription price

Avg: $140

FARHA KHAN MD

Endocrinology, Diabetes Metabolism

2,880

$576K

333
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 42%

$200
Average prescription price

Avg: $140

LUKE BENEDICT MD

Endocrinology, Diabetes Metabolism

2,774

$576K

298
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 42%

$208
Average prescription price

Avg: $140

GREGORY MUCHA MD

Endocrinology, Diabetes Metabolism

2,592

$521K

269
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 42%

$201
Average prescription price

Avg: $140

ROBERT SJOBERG MD

Endocrinology, Diabetes Metabolism

2,445

$486K

224
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 42%

$199
Average prescription price

Avg: $140

SUSAN ATAMIAN MD

Endocrinology, Diabetes Metabolism

2,244

$369K

265
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 42%

$165
Average prescription price

Avg: $140

C ROWAN DEBOLD

Endocrinology, Diabetes Metabolism

2,068

$311K

243
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 42%

$150
Average prescription price

Avg: $140

KATHERINE PILLOTE MD

Endocrinology, Diabetes Metabolism

2,034

$326K

211
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 42%

$160
Average prescription price

Avg: $140

ANNE-MARIE LEE MD

Endocrinology, Diabetes Metabolism

1,899

$200K

270
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 42%

$105
Average prescription price

Avg: $140

SUMIT BHAGRA MBBS

Endocrinology, Diabetes Metabolism

1,885

$252K

265
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 42%

$134
Average prescription price

Avg: $140

MARK HOLM MD

Endocrinology, Diabetes Metabolism

1,815

$402K

167
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 42%

$222
Average prescription price

Avg: $140

REBECCA MOXNESS

Endocrinology, Diabetes Metabolism

1,811

$308K

197
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 42%

$170
Average prescription price

Avg: $140

CHRISTOPHER BALKANY MD

Endocrinology, Diabetes Metabolism

1,782

$306K

190
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 42%

$172
Average prescription price

Avg: $140

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank